Delivery Order SPE2DB22D2009-SPE2DB24FL6YT
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on February 13, 2024. The contract is for the supply of Rifampin 300 mg capsules and has a ceiling value of $15,215.32. It is a firm fixed-price contract with a performance period ending on February 14, 2024. The contract was not set aside for a specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $10,884.84 contract is for the delivery of 4,565,404,267 units of Rifampin 300 mg capsules, with a period of performance through August 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that supplies a wide range of medical products and drugs to federal agencies, including the military. This contract is part of...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4560298440 - Rifampin 300 mg capsules, with a ceiling value of $33,762.13 and a period of performance through March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,992.80 and an ultimate completion date of February 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,458.20 firm fixed-price contract is for the delivery of Rifampin 300 mg capsules, a critical medication used to treat various infectious diseases. The contract has a completion date of February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Rifampin 300 mg capsules. The firm-fixed-price contract has a ceiling value of $10,688.90 and a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
- This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Rifampin 300 mg capsules, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $18,609.46 and an ultimate completion date of August 29, 2024. It is a firm-fixed-price contract, with no set-aside designation....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,187.50 firm-fixed-price contract is for the delivery of RIFAMPIN 300 MG CAPSULE 60S, a medication. The order has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The company also holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Rifampin 300 mg capsules and has a ceiling value of $65,431.34. The contract has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL6YTDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,954,752 units of Rifampin 300 mg capsules, with a ceiling value of $6,021.70 and a completion date of December 1, 2023. The contract is a Firm Fixed Price, Delivery Order type, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 11/30/23 |